Adding Silo Pharma (SILO) $3.50 to Watch List.
Look What We Found!
We launched the Psychedelic Stock Review a little more than a year ago and decided to take a wait-and-see attitude.
We...
Silo Pharma (SILO) Announces Positive Study Results of SPU- 21 for Arthritis
SPU-21 effective in controlling arthritis progression.
SPU-21 Demonstrates Positive Data in Arthritis Suppression using Silo’s Novel Joint Homing Peptide
ENGLEWOOD CLIFFS, NJ, Dec. 30, 2022 (GLOBE...
Silo Pharma (SILO) Trades up 90% Friday, With 23 Million Shares Traded!
And We Weren't Watching!
It was Friday after all, and the last day of the year, and we were celebrating our 78% gain in Ardelyx...
Doubling Down After ATAI’s (ATAI) Anti Depression Treatment Bombs in Front of FDA.
Both a bad day and a Good day for Psychedelics. The Psychedelic Sector Holds Firm.
Atai was founded in 2018 and went public in June...
Silo Pharma (SILO) $2.67 Announces $1 Million Stock Buyback.
Yes it doesn't sound like a lot of money on the surface. But the stock is so grossly undervalued (in our opinion) and there...
SILO Pharma (SILO) Gains 53%
For Now, Volatility Remains and the Traders, Seem to be Having the Most Fun.
Silo Pharma Gains 53% Intraday on Patent (Ketamine) Related News
Our opinion...
Revive Therapeutics (RVVTF) Advancing MDMA Thermal Patch.
Two News Reports Related to Revives Upcoming Microneedle Patch Technology
While we are still laser focused on Revive having a successful meeting with the FDA...
Silo Pharma (SILO) $2.25, Now Our Favorite Psychedelic.
We Liked it at $3.50, we Love it at $2.25.
Down but not out. Now trading below the cash they have in the bank, this...
Is ATAI Live Sciences (ATAI) $2.00, Finally Turning?
After dropping 94% from post IPO high from $19.45, a loss exceeding $3 billion and change, ATAI is in the early stages of recovery (in our opinion)...
The Ketamine Endgame. Silo Pharmaceutical (SILO).
James Kuo, M.D. the Vice President of R&D for Silo Pharma (SILO) will speak at the 3rd Annual Psychedelic Therapeutics and Drug Development Conference.
Dr....